𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of intensification and maintenance programs in the treatment of acute lymphoblastic leukemia

✍ Scribed by Federico Sackmann-Muriel; Eva Svarch; Mariana Eppinger-Helft; Jorge L. Braier; Santiago Pavlovsky; Liliana Guman; Berta Vergara; Carlos Ponzinibbio; Renato Failace; Guy E. Garay; Enrique Bugnard; Félix G. Ojeda; Roberto de Bellis; Susana R. De Sijvarger; Jorge Saslavsky

Publisher
John Wiley and Sons
Year
1978
Tongue
English
Weight
856 KB
Volume
42
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Remission maintenance of adult acute lym
Remission maintenance of adult acute lymphoblastic leukemia
✍ Armitage, James O. ;Burns, C. Patrick 📂 Article 📅 1977 🏛 John Wiley and Sons 🌐 English ⚖ 325 KB

## Abstract This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400

Pneumocystis carinii pneumonia during ma
Pneumocystis carinii pneumonia during maintenance treatment of childhood acute lymphoblastic leukemia
✍ Poulsen, Anja ;Demeny, Ann Kathrin ;Plum, Charlotte Bang ;Nielsen, Kim Gjerum ;S 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 96 KB

## Abstract ## Background Pneumocystis carinii pneumonia (PCP) is a wellknown risk among patients with deficient T‐cell function such as children treated for acute lymphoblastic leukemia (ALL). The purpose of this study was to estimate the risk for PCP during maintenance treament (MT) to identify

Treatment of acute lymphoblastic leukemi
Treatment of acute lymphoblastic leukemia in adults
✍ Prof. Tiziano Barbui; Renato Bassan; Teodoro Chisesi; Raffaele Battista; Sergio 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB

Thirty-seven adult patients with acute lymphoblastic leukemia were treated with a protocol called HEAV'D including Adriamycin, Vincristine, L-Asparaginase, Cyclophosphamide and Dexamethasone. The complete remission rate was 70 per cent. The median duration of remission was more than 30 months. Patie